BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7422900)

  • 1. Plasma concentrations of 9-deoxo-16-dimethyl-9-methylene-PGE2 in rhesus monkeys after administration by various routes.
    Kimball FA; Cornette JC; Bundy GL; Kirton KT
    Prostaglandins; 1980 Sep; 20(3):559-69. PubMed ID: 7422900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2 in human plasma by GC-MS, RIA and HPLC.
    Gréen K; Kimball FA; Thornburgh BA; WickremaSinha AJ
    Prostaglandins; 1980 Oct; 20(4):767-80. PubMed ID: 7465866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
    Bygdeman M; Christensen N; Gréen K; Lundström V
    Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of 9-deoxo-16,16-dimethyl-9-methylene-PGE2 in connection with its development as an abortifacient.
    Gréen K; Vesterqvist O; Bygdeman M; Christenssen NJ; Bergström S
    Prostaglandins; 1982 Oct; 24(4):451-66. PubMed ID: 7178484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
    Ballard CA
    Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination.
    Gréen K; Bygdeman M; Swahn ML; Vesterqvist O; Christensen NJ
    Prostaglandins Leukot Essent Fatty Acids; 1988 Aug; 33(2):121-7. PubMed ID: 3174718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
    Brenner PF; Marrs RP; Roy S; Mishell DR
    Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatation.
    Bygdeman M; Bremme K; Christensen N; Lundström V; Gréen K
    Contraception; 1980 Nov; 22(5):471-83. PubMed ID: 7471738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravaginal administration of 9-deoxo-9-methylene-16,16-dimethyl PGE2 for cervical dilation prior to suction curettage.
    Shapiro AG; Lasseter K; Cobiella A; Domenzain M
    Int J Gynaecol Obstet; 1982 Apr; 20(2):137-40. PubMed ID: 6125434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs.
    Lauersen NH; Graves ZR
    J Reprod Med; 1984 Feb; 29(2):133-5. PubMed ID: 6708030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
    Borten M; DiLeo LA; Friedman EA
    Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative dilatation of the cervix uteri by vaginal application of 9-deoxo-16, 16-dimethyl-9-methylene PGE2 in pregnancy interruption during the 1st trimester. Double-blind clinical study].
    Friedli A; De Grandi P
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):215-21. PubMed ID: 3522723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancy.
    Swahn ML; Gottlieb C; Green K; Bygdeman M
    Contraception; 1990 May; 41(5):461-73. PubMed ID: 2347194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activity of 9-deoxo-9-methylene and related prostaglandins.
    Bundy GL; Kimball FA; Robert A; Aiken JW; Maxey KM; Sebek OK; Nelson NA; Sih JC; Miller WL; Hsi RS
    Adv Prostaglandin Thromboxane Res; 1980; 6():355-63. PubMed ID: 7386275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prostaglandin-analogue-9-deoxo-16,16-dimethyl-9-methylene-PGE2 inhibits the antidiuretic effect of vasopressin (AVP) in the conscious sheep.
    Christensen NJ; Bygdeman M; Greén K; Jonasson H; Rundgren M; Wallin CJ; Vesterqvist O; Leksell LG
    Pflugers Arch; 1984 Dec; 402(4):360-3. PubMed ID: 6522243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2 in humans.
    Steffenrud S
    Drug Metab Dispos; 1983; 11(3):255-65. PubMed ID: 6135585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical dilatation with meteneprost vaginal suppositories in first trimester abortion.
    Somell C; Olund A
    Contraception; 1986 Feb; 33(2):189-94. PubMed ID: 3698595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water diuretic effect of intravenously administered 9-deoxo-16, 16-dimethyl-9-methylene-PGE2 in conscious man.
    Leksell LG; Christensen NJ; Vesterqvist O; Wallin CJ
    Clin Physiol; 1984 Dec; 4(6):449-59. PubMed ID: 6542832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prostaglandin E2 analogue suppository on blood loss in suction abortion.
    Sidhu MS; Kent DR
    Obstet Gynecol; 1984 Jul; 64(1):128-30. PubMed ID: 6738937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin vaginal suppositories in non pregnant women requiring cervical dilatation prior to hysteroscopy.
    Hald F; Kristoffersen SE; Gregersen E
    Acta Obstet Gynecol Scand; 1988; 67(3):219-22. PubMed ID: 3051874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.